Saturday - November 2, 2024
Durbin Leads Senators In Demanding Answers From Pfizer, Eli Lilly On New Telehealth Platforms Amid Concerns Of Inappropriate Prescribing
October 22, 2024
WASHINGTON, Oct. 22 -- Sen. Richard J. Durbin, D-Illinois, issued the following news release:

In Letters to Pfizer and Eli Lilly, Durbin, Sanders, Welch, and Warren request details about whether the companies' new advertising & telehealth schemes create conflicts of interest that steer patients toward particular medications

CHICAGO U.S. Senate Majority Whip Dick Durbin (D-IL) sent a letter to the CEOs of Pfizer Inc. and Eli Lilly demanding answers about the pharmace . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products